Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical Trials
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
SUMMARY: Parkinson's disease (PD) is the second most common neurodegenerative disorder with an estimated 4 million patients worldwide. L‐dopa is standard, and often initial, therapy for patients with this condition; however, with continued dopaminergic treatment and as the disease progresses, the majority of patients experience complications such as “wearing‐off” symptoms, dyskinesias, and other motor complications. These complications may become disabling and profoundly affect quality of life. Treatment modification and combination therapies with L‐dopa, dopamine agonists, monoamine oxidase type B inhibitors, and catechol‐O‐methyltransferase inhibitors are commonly used to manage complications. In recent years regulatory agencies, clinical researchers, and sponsors have widely accepted and utilized changes in “ON” and “OFF” time measured by Patient Hauser Diaries as endpoints for measuring efficacy of therapeutics seeking approval for symptomatic treatment of PD. Successful antiparkinsonian medications have been associated with treatment effects of more than 1 h in either reduction of “OFF” time of increase in “ON” time. Accurate “ON” and “OFF” time registration during clinical studies requires rigorous patient training. Reduced compliance, recall bias and diary fatigue are common problems seen with patient diary reported measures. Electronic diaries may help reducing some of these problems but may be associated with other challenges in large, multicenter studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Patient compliance with paper and electronic diaries
Stone, A. A., Shiffman, S., Schwartz, J. E., Broderick, J. E., & Hufford, M. R. (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(02)00320-3 · Cited by 910
Cited by
Automated Assessment of Bradykinesia and Dyskinesia in Parkinson's Disease
Griffiths, R. I., Kotschet, K., Arfon, S., Xu, Z. M., Johnson, W., Drago, J., Evans, A., Kempster, P., Raghav, S., & Horne, M. K. (2012) · Journal of Parkinson’s Disease · doi:10.3233/jpd-2012-11071 · Cited by 280
Rodríguez-Martín, D., Samà, A., Pérez-López, C., Català, A., Moreno Arostegui, J. M., Cabestany, J., Bayés, À., Alcaine, S., Mestre, B., Prats, A., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171764 · Cited by 237
Wearable sensor-based objective assessment of motor symptoms in Parkinson’s disease
Ossig, C., Antonini, A., Buhmann, C., Classen, J., Csoti, I., Falkenburger, B., Schwarz, M., Winkler, J., & Storch, A. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-015-1439-8 · Cited by 164
A clinical view on the development of technology‐based tools in managing Parkinson's disease
Maetzler, W., Klucken, J., & Horne, M. (2016) · Movement Disorders · doi:10.1002/mds.26673 · Cited by 162
“The continuous objective assessment of fluctuations is of high clinical relevance because comparable to dyskinesia assessment, there is reduced compliance, recall bias, and diary fatigue.(37) Furthermore, fluctuations may not be limited to advanced PD, but can occur even at early stages of the disease.”
BackgroundClinician versus machine: Reliability and responsiveness of motor endpoints in Parkinson's disease
Heldman, D. A., Espay, A. J., LeWitt, P. A., & Giuffrida, J. P. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.02.022 · Cited by 156
“Similarly, patientcompleted diaries can yield unreliable data due to inadequate compliance, recall bias, or faulty self-assessment [14].”
Background
Metadata
- Authors
- Papapetropoulos, S. (.
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2011-06-07
- Volume
- 18
- Issue
- 5
- Pages
- 380-387
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- OpenAlex
- W1492061961
- Cited by
- 145
- References
- 3
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical Trials. https://app.cochat.ai/papers/10.1111/j.1755-5949.2011.00253.x
- The paper
- Papapetropoulos, S. (. (2012). Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical Trials. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/j.1755-5949.2011.00253.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.